Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia. 28415578 2017
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease BEFREE However, we did not confirm expression of the proteins in acute lymphoblastic leukemia cases with endogenous ERG deletion. 27494621 2016
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. 27776115 2016
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease CTD_human Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. 27776115 2016
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE Overexpression of the oncogene ERG (ETS-related gene) is an adverse prognostic factor in acute myeloid and T-cell lymphoblastic leukemia (AML and T-ALL). 24504051 2014
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 GeneticVariation disease BEFREE An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. 24064621 2014
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia. 20570349 2011
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease BEFREE High BAALC expression correlated with a higher frequency of early T-ALL (P < .0001), CD34 positivity (P < .0001), coexpression of myeloid markers (P = .0001), and high ERG expression (P = .03). 17646667 2007
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease BEFREE On multivariable analysis high ERG expression (P = .005), immunophenotypic subgroups (early v mature v thymic T-ALL; overall P = .04), HOX11L2 positivity (P = .055), and absence of HOX11 (P = .017) were independent adverse risk factors predicting RFS. 16954520 2006
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 GeneticVariation disease BEFREE TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease. 16263589 2005
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease LHGDN [Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia]. 16215946 2005
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease BEFREE The pre-B Reh-6 leukemic cells do not express membrane interleukin-2 (IL-2)-R alpha (Tac or p55) chain; however, their incubation with PMA induces the expression of both high and low affinity IL-2-R. Northern analysis of nonstimulated Reh-6 as well as leukemic cells from patients with acute B cell precursor lymphoblastic leukemia displayed a constitutive expression of p55 mRNA transcripts, which could be enhanced by PMA. 2243505 1990